Company:  BIOSTAGE, INC. (BSTG)
Form Type:  10-K
Filing Date:  3/27/2015 
CIK:  0001563665 
Address:  84 OCTOBER HILL ROAD
SUITE 11
 
City, State, Zip:  HOLLISTON, Massachusetts 01746 
Telephone:  (774) 233-7300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.00  
Change: 
-0.40 (-16.67%)  
Trade Time: 
10:45 AM EST  
Market Cap: 
$21.38M
Trade BSTG now with 

© 2021  
Description of Business
We are a biotechnology company developing bioengineered organ implants based on our novel technology. Our technology is comprised of a proprietary biocompatible scaffold, which is the foundation of our CellframeTMtechnology, that is seeded with the patient's own mesenchymal stromal cells to form our CellspanTMimplant, combining the clinically proven principles of tissue engineering, cell biology and materials science. Our platform technology is being developed to treat life-threatening conditions of the esophagus, bronchus and trachea. By focusing on these underserved patients, we hope to dramatically improve the treatment paradigm for these patients. We believe our technology may provide surgeons a new paradigm to address life-threatening conditions of the esophagus, bronchus, and trachea due to congenital abnormalities, diseases, infections and traumas.
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business.
        NAME AND TITLE
      Item 1A. Risk Factors.
      Item 1B. Unresolved Staff Comments.
      Item 2. Properties.
      Item 3. Legal Proceedings.
      Item 4. Mine Safety Disclosures.
    PART II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures about ...
      Item 8. Financial Statements and Supplementary Data.
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures.
      Item 9B. Other Information.
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance.
      Item 11. Executive Compensation.
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accounting Fees and Services.
    PART IV
      Item 15. Exhibits, Financial Statement Schedules.
    Report of Independent Registered Public Accounting Firm
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    CASH FLOW
    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 4.2
  EXHIBIT 21.1
    SUBSIDIARIES
  EXHIBIT 23.1
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT 31.1
    Certification
  EXHIBIT 31.2
    Certification
  EXHIBIT 32.1
    CERTIFICATION OF PERIODIC FINANCIAL REPORT
  EXHIBIT 32.2
    CERTIFICATION OF PERIODIC FINANCIAL REPORT